Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial

dc.contributor.authorBangirana, Paul
dc.contributor.authorConroy, Andrea L.
dc.contributor.authorOpoka, Robert O.
dc.contributor.authorSemrud-Clikeman, Margaret
dc.contributor.authorJang, Jeong H.
dc.contributor.authorApayi, Claire
dc.contributor.authorKakuru, Abel
dc.contributor.authorMuhindo, Mary K.
dc.contributor.authorGeorgieff, Michael K.
dc.contributor.authorDorsey, Grant M.
dc.contributor.authorKamya, Moses R.
dc.contributor.authorHavlir, Diane
dc.contributor.authorJohn, Chandy C.
dc.contributor.departmentPediatrics, School of Medicine
dc.date.accessioned2024-01-02T14:46:21Z
dc.date.available2024-01-02T14:46:21Z
dc.date.issued2023
dc.description.abstractBackground: Malaria in pregnancy has been associated with worse cognitive outcomes in children, but its association with behavioral outcomes and the effectiveness of malaria chemoprevention on child neurodevelopment are not well characterized. Methods: To determine if more effective malaria chemoprevention in mothers and their children results in better neurodevelopment, 305 pregnant women were randomly assigned to 3 doses of sulfadoxine-pyrimethamine, 3 doses of dihydroartemisinin-piperaquine (DP), or monthly DP during pregnancy, and their 293 children were assigned to DP every 3 months or monthly DP from 2 to 24 months of age. Cognition, language, and motor function were assessed at 12, 24. and 36 months of age, and attention, memory, behavior, and executive function were assessed at 24 and 36 months of age. Results: Children of mothers with versus without malaria in pregnancy had worse scores on cognitive, behavioral, and executive function outcomes at 24 months. Clinical malaria in children within the first 12 months was similarly associated with poorer scores in behavior and executive function at 24 months, language at 24 and 36 months, and motor function scores at 36 months. However, more effective malaria chemoprevention in the mothers and children was not associated with better outcomes. Conclusions: Malaria in pregnancy was associated with worse cognitive, behavioral, and executive function scores in affected children, but more effective malaria chemoprevention measures did not result in better outcomes. Malaria chemoprevention prior to and early in gestation and with even higher efficacy in mothers and children may be required to prevent neurodevelopmental impairment in children.
dc.eprint.versionFinal published version
dc.identifier.citationBangirana P, Conroy AL, Opoka RO, et al. Effect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial. Clin Infect Dis. 2023;76(4):600-608. doi:10.1093/cid/ciac815
dc.identifier.urihttps://hdl.handle.net/1805/37533
dc.language.isoen_US
dc.publisherOxford University Press
dc.relation.isversionof10.1093/cid/ciac815
dc.relation.journalClinical Infectious Diseases
dc.rightsPublisher Policy
dc.sourcePMC
dc.subjectChemoprevention
dc.subjectDevelopment
dc.subjectMalaria
dc.subjectPregnancy
dc.titleEffect of Malaria and Malaria Chemoprevention Regimens in Pregnancy and Childhood on Neurodevelopmental and Behavioral Outcomes in Children at 12, 24, and 36 Months: A Randomized Clinical Trial
dc.typeArticle
ul.alternative.fulltexthttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10169410/
Files
Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ciac815.pdf
Size:
692.38 KB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: